SIEMENS HEALTH ADR/050 Cash Flow Conversion Efficiency
SIEMENS HEALTH ADR/050 cash flow conversion efficiency. Based on the latest financial reports, SIEMENS HEALTH ADR/050 (SHL1) has a cash flow conversion efficiency ratio of 0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€492.00 Million ≈ $575.20 Million USD) by net assets (€18.48 Billion ≈ $21.61 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SIEMENS HEALTH ADR/050 market capitalisation for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of SIEMENS HEALTH ADR/050 (2022–2024)
Cash flow conversion efficiency of SIEMENS HEALTH ADR/050 from 2022 to 2024. This chart illustrates how SIEMENS HEALTH ADR/050's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for SIEMENS HEALTH ADR/050 for real-time trading data and today's change.
SIEMENS HEALTH ADR/050 Cash Flow Conversion Ratio Explained
SIEMENS HEALTH ADR/050 cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
SIEMENS HEALTH ADR/050 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SIEMENS HEALTH ADR/050 ranked by their cash flow conversion efficiency. Review SIEMENS HEALTH ADR/050 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Waste Connections Inc
TO:WCN
|
0.090x |
|
Polski Koncern Naftowy ORLEN SA
WAR:PKN
|
0.089x |
|
Vistra Energy Corp
NYSE:VST
|
0.281x |
|
Swedbank AB (publ)
ST:SWED-A
|
-0.020x |
|
Samsung Biologics Co Ltd
KO:207940
|
0.075x |
|
State Street Corp
NYSE:STT
|
-0.082x |
|
Nike Inc
NYSE:NKE
|
0.031x |
|
Hangzhou Hikvision Digital Technology Co Ltd
SHE:002415
|
0.089x |
Annual Cash Flow Conversion Efficiency for SIEMENS HEALTH ADR/050 (2022–2024)
The table below shows the annual cash flow conversion efficiency of SIEMENS HEALTH ADR/050 from 2022 to 2024. Also see SIEMENS HEALTH ADR/050 balance sheet assets for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | €18.25 Billion ≈ $21.33 Billion |
€2.83 Billion ≈ $3.30 Billion |
0.155x | +32.52% |
| 2023-09-30 | €18.13 Billion ≈ $21.20 Billion |
€2.12 Billion ≈ $2.48 Billion |
0.117x | -7.35% |
| 2022-09-30 | €19.85 Billion ≈ $23.21 Billion |
€2.50 Billion ≈ $2.93 Billion |
0.126x | -- |
About SIEMENS HEALTH ADR/050
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound sys… Read more